Grupo de Investigación Pharmananogene

• Apaolaza PS, del Pozo-Rodríguez A, Torrecilla J, Rodríguez-Gascón A, Rodríguez JM, Friedrich U, Weber BHF, Solinís MA  Solid Lipid Nanoparticle-based vectors intended for the treatment of X-linked juvenile retinoschisis by gene therapy: In vivo approaches in Rs1h-deficient mouse model Journal of Controlled Release,  2015;  217,  273 - 283
• Lertxundi U, Isla A, Solinís MA, Domingo-Echaburu S, García M, Aguirre C, García-Moncó JC  Adverse Reactions to Antipsychotics in Parkinson Disease: An Analysis of the Spanish Pharmacovigilance Database Clinical Neuropharmacology,  2015;  38,  69 - 84
• Lertxundi U, Isla A, Solinís MA, Domingo-Echaburu S, Hernandez R, García-Moncó JC  A Proposal to Prevent Omissions and Delays of Antiparkinsonian Drug Administration in Hospitals The Neurohospitalist,  2015;  5,  53 - 54
• Lertxundi U, Isla A, Solinis MA, Domingo-Echaburu S, Hernandez R, Peral-Aguirregoitia J, Medrano J  Anticholinergic burden in Parkinson's disease inpatients European Journal of Clinical Pharmacology,  2015;  71,  1271 - 1277
• Rodríguez-Gascón A, del Pozo-Rodríguez A, Isla Ruiz A, Solinís Aspiazu MA  Vaginal gene therapy Advanced Drug Delivery Reviews,  2015;  92,  71 - 83
• Asín-Prieto E, Soraluce A, Trocóniz IF, Campo E, Sáez de Ugarte J, Rodriguez-Gascón A, Isla A  Population pharmacokinetic models for cefuroxime and metronidazole used in combination as prophylactic agents in colorectal surgery: Model-based evaluation of standard dosing regimens International Journal of Antimicrobial Agents,  2015;  45,  504 - 511
• Asín-Prieto E, Rodríguez-Gascón A, Isla A  Applications of the Pharmacokinetic/Pharmacodynamic (PK/PD) Analysis of Antimicrobial Agents Journal of Infection and Chemotherapy,  2015;  21,  319 - 329
• Canut A, Isla A, Rodríguez-Gascón A  Pharmacokinetic/pharmacodynamic analysis to evaluate ceftaroline fosamil dosing regimens for the treatment of community-acquired bacterial pneumonia and complicated skin and skin-structure infections in patients with normal and impaired renal function International Journal of Antimicrobial Agents,  2015;  45,  399 - 405
• Otaegui D, Masdeu C, Aldaba E, Vara Y, Zubia A, San Sebastián E, Alcalá M, Villafruela S, Cossío FP, Rodríguez-Gascón A  Development and validation of a LC-MS assay for the quantification of IKH12 a novel anti-tumor candidate in rat plasma and tissues and its application in a pharmacokinetic study Biomedical Chromatography,  2015;  29,  1249 - 1258
• Canut A, Aguilar L, Cobo J, Giménez MJ, Rodríguez-Gascón A  Análisis farmacocinético-farmacodinámico en microbiología: herramienta para evaluar el tratamiento antimicrobiano Enfermedades infecciosas y microbiología clínica,  2015;  33,  48 - 57
• Torrecilla J, del Pozo-Rodríguez A, Apaolaza PS, Solinís MA, Rodríguez-Gascón A  Solid lipid nanoparticles as non-viral vector for the treatment of chronic hepatitix C by RNA interference International Journal of Pharmaceutics,  2015;  479,  181 - 188
• Solinís MA, del Pozo-Rodríguez A, Apaolaza PS, Rodríguez-Gascón A  Treatment of ocular disorders by gene therapy European Journal of Pharmaceutics and Biopharmaceutics,  2015;  95,  331 - 342
• Ruiz de Garibay A, Solinís MA, del Pozo-Rodríguez A, Apaolaza PS, Shen JS, Rodríguez-Gascón A  Solid lipid nanoparticles as non-viral vectors for gene transfection in a cell model of Fabry disease Journal of Biomedical Nanotechnology,  2015;  11,  500 - 511